Categories: Healthcare

Clinical Chemistry Analyzers Market Report: Global Size, Share, Growth Analysis And Forecast 2033

The Clinical Chemistry Analyzers Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Clinical Chemistry Analyzers Market:

https://www.thebusinessresearchcompany.com/report/clinical-chemistry-analyzers-global-market-report

According to The Business Research Company’s Clinical Chemistry Analyzers Global Market Report 2024, The clinical chemistry analyzers market size has grown strongly in recent years. It will grow from $14.29 billion in 2023 to $15.2 billion in 2024 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to growing aging population, disease prevalence and diagnostics, automation in laboratories, increasing healthcare expenditure, demand for point-of-care testing.

The clinical chemistry analyzers market size is expected to see strong growth in the next few years. It will grow to $19.49 billion in 2028 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to integration of artificial intelligence (ai), expanding applications in personalized medicine, rising awareness of preventive healthcare, point-of-care molecular diagnostics, emerging markets growth. Major trends in the forecast period include lab-on-a-chip technology, real-time monitoring capabilities, environmental sustainability initiatives, interoperability with electronic health records, virtual clinical chemistry analyzer platforms.

The increasing incidence of infectious and chronic disorders is expected to propel the growth of the clinical chemistry analyzer market in the coming future. Infectious diseases refer to diseases brought on by pathogens, which are dangerous substances that enter the human body via food or from a person. Chronic diseases often last for three months or more and may worsen with time. The increasing incidence of infectious and chronic disorders is booming the clinical chemistry analyzer market, as it is used to analyze specimen samples to diagnose and manage disease. For instance, in September 2022, according to Johns Hopkins University, a US-based private university, in 2021, more than 353,000 COVID-19-related fatalities had been documented, surpassing the 352,000 cases noted in 2020. Therefore, the increasing incidence of infectious and chronic disorders drives the clinical chemistry analyzer market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=12462&type=smp

The clinical chemistry analyzers market covered in this report is segmented –
1) By Product: Clinical Chemistry Analyzers, Clinical Chemistry Reagents, Other Products

2) By Analyzer Technology: Semi-Automated Clinical Chemistry Analyzers, Fully Automated Clinical Chemistry Analyzers

3) By Test Type: Basic Metabolic Panels, Electrolyte Panels, Liver Panels, Lipid Profiles, Renal Panels, Thyroid Function Panels, Specialty Chemical Tests

4) By End-User: Hospitals, Academic Research Centers, Diagnostic Laboratories, Other End-Users

Product innovation is the key trend gaining popularity in the clinical chemistry analyzer market. Major companies operating in the clinical chemistry analyzer market are concentrating on creating revolutionary products to improve their market share. For instance, in July 2022, EDAN Instruments Inc., a China-based manufacturing company of clinical chemistry analyzers and other diagnostic tools, launched the first-ever unique and innovative POC (Point-of-Care) fluorescence-based CO-OX blood gas and chemistry analysis device, the i20. The i20 was furnished with approximately 45 parameters at the 74th American Association for Clinical Chemistry Annual Scientific Meeting and Clinical Laboratory Exposition (2022 AACC), ranging from blood gases and electrolytes to CO-oximetry. The new method is intended to lessen the workload in specific patient care settings, such as neonatal intensive care units, critical care units, pulmonary units, hospital emergency rooms, and operating rooms. The technology’s photoluminescent biosensor dramatically improves accuracy and stability while obviating the need for space, personnel training, and maintenance.

The clinical chemistry analyzers market report table of contents includes:
1. Executive Summary